Carotid Artery Stent Procedures with CC DRG Reimbursement

DRG 035 covers carotid artery stent procedures with a Complication or Comorbidity and defines the inpatient clinical scope for resource use during endovascular carotid interventions. It matters for inpatient reimbursement because the Diagnosis-Related Group assignment, influenced by coded complications and comorbidities, affects Medicare payment levels for hospitals.

DRG 035 Overview

DRG 035 covers inpatient admissions for carotid artery stent procedures performed in the presence of a Complication or Comorbidity and encompasses patients treated for carotid artery stenosis using endovascular stent placement when an associated complication or comorbidity is coded. This Diagnosis-Related Group groups cases by clinical resource intensity to determine Medicare inpatient payment, reflecting additional costs when comorbid conditions or perioperative complications are present. Accurate coding of the principal procedure and associated diagnoses affects case assignment and resulting payment. The designation is relevant to vascular surgery, interventional cardiology, and interventional radiology services involved in care and billing.

Acute procedural optimization studies evaluating peri-procedural strategies to reduce immediate complications: These trials focus on intra-procedural techniques, antithrombotic protocols, and device deployment methods in patients undergoing carotid artery stent placement for symptomatic or high-risk asymptomatic carotid stenosis. The patient population includes adults with significant carotid atherosclerosis requiring stenting, often with comorbid coronary or cerebrovascular disease, and the aim is to lower periprocedural stroke, myocardial infarction, and access-site complications. Results directly inform interventional practice patterns and short-term resource utilization, which is critical for hospital quality metrics and payers concerned with index admission costs and readmission risk.
Comparative effectiveness studies of carotid stenting versus surgical or medical alternatives in high-risk surgical candidates: These studies compare outcomes such as stroke-free survival, perioperative morbidity, and functional status between carotid artery stent recipients and patients managed with carotid endarterectomy or optimized medical therapy, often stratified by surgical risk profiles, age, and anatomical lesion characteristics. The population typically includes patients judged high-risk for open surgery or those with recurrent restenosis after prior interventions; the objective is to define which subgroups derive net benefit from stenting. Findings guide referral patterns, procedure selection, and payer coverage decisions by clarifying comparative costs, complication rates, and long-term efficacy across treatment strategies.
Post-discharge and longitudinal outcomes research on restenosis, secondary stroke prevention, and rehabilitation needs: These observational cohorts and pragmatic trials examine long-term patency, rates of restenosis, adherence to antiplatelet therapy, secondary stroke incidence, cognitive and functional recovery, and utilization of outpatient services after carotid stenting. The studied patients include survivors of the index hospitalization across a range of comorbidities (e.g., atrial fibrillation, diabetes, peripheral vascular disease) to identify predictors of readmission, downstream interventions, and rehabilitation resource use. This evidence helps providers optimize follow-up protocols and helps payers project long-term costs and outcomes associated with different post-discharge management strategies.

Acute procedural optimization studies evaluating peri-procedural strategies to reduce immediate complications: These trials focus on intra-procedural techniques, antithrombotic protocols, and device deployment methods in patients undergoing carotid artery stent placement for symptomatic or high-risk asymptomatic carotid stenosis. The patient population includes adults with significant carotid atherosclerosis requiring stenting, often with comorbid coronary or cerebrovascular disease, and the aim is to lower periprocedural stroke, myocardial infarction, and access-site complications. Results directly inform interventional practice patterns and short-term resource utilization, which is critical for hospital quality metrics and payers concerned with index admission costs and readmission risk.
Comparative effectiveness studies of carotid stenting versus surgical or medical alternatives in high-risk surgical candidates: These studies compare outcomes such as stroke-free survival, perioperative morbidity, and functional status between carotid artery stent recipients and patients managed with carotid endarterectomy or optimized medical therapy, often stratified by surgical risk profiles, age, and anatomical lesion characteristics. The population typically includes patients judged high-risk for open surgery or those with recurrent restenosis after prior interventions; the objective is to define which subgroups derive net benefit from stenting. Findings guide referral patterns, procedure selection, and payer coverage decisions by clarifying comparative costs, complication rates, and long-term efficacy across treatment strategies.
Post-discharge and longitudinal outcomes research on restenosis, secondary stroke prevention, and rehabilitation needs: These observational cohorts and pragmatic trials examine long-term patency, rates of restenosis, adherence to antiplatelet therapy, secondary stroke incidence, cognitive and functional recovery, and utilization of outpatient services after carotid stenting. The studied patients include survivors of the index hospitalization across a range of comorbidities (e.g., atrial fibrillation, diabetes, peripheral vascular disease) to identify predictors of readmission, downstream interventions, and rehabilitation resource use. This evidence helps providers optimize follow-up protocols and helps payers project long-term costs and outcomes associated with different post-discharge management strategies.

OpenPayer

Summary & Overview

Carotid Artery Stent Procedures with CC: Inpatient Reimbursement Overview

DRG 035 Overview

Clinical Trials

Related Codes

Clinical Trials

Related Codes